logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Abnormal movement in Hong Kong stocks: Goldwind Technology (02208.HK) rises nearly 4% as renewable energy accelerates deployment. Company's wind turbine business gross profit margin significantly improves as expected.

date
05/09/2025
According to the Wisdom Finance APP, Goldwind Technology (02208.HK) has risen by nearly 4%, as of the time of publication, it has risen by 3.07% to 9.06 Hong Kong dollars, with a turnover of 68.0624 million Hong Kong dollars.
Latest
5 m ago
(06069) obtained an increase of 2.671 million shares of the company by its controlling shareholder and Chairman of the Board, Tung Chi Fung.
5 m ago
Junjie Group Holdings (08188.HK) spent HK$107,000 on September 5 to repurchase 100,000 shares.
6 m ago
New stock news | Hehe Information plans to list in Hong Kong. The China Securities Regulatory Commission requires additional explanations on the reasons for the company and its subsidiaries participating in financial derivatives trading.
6 m ago
New stock news | Shanghai Longqi plans to go public in Hong Kong. The China Securities Regulatory Commission requires an explanation of the actual operation of medical device business, etc.
7 m ago
Haplox Biopharma-B (02142.HK) issued 45,022,000 shares in accordance with the placement agreement.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.